Cargando…
Locally Advanced Pancreatic Cancer: Percutaneous Management Using Ablation, Brachytherapy, Intra-arterial Chemotherapy, and Intra-tumoral Immunotherapy
PURPOSE OF REVIEW: Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive neoplasms, bearing a terrible prognosis. Stage III tumors, also known as locally advanced pancreatic cancer (LAPC), are unresectable, and current palliative chemotherapy regimens have only modestly improved surv...
Autores principales: | Timmer, Florentine E.F., Geboers, Bart, Nieuwenhuizen, Sanne, Schouten, Evelien A.C., Dijkstra, Madelon, de Vries, Jan J.J., van den Tol, M. Petrousjka, de Gruijl, Tanja D., Scheffer, Hester J., Meijerink, Martijn R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052234/ https://www.ncbi.nlm.nih.gov/pubmed/33864144 http://dx.doi.org/10.1007/s11912-021-01057-3 |
Ejemplares similares
-
Microwave Ablation, Radiofrequency Ablation, Irreversible Electroporation, and Stereotactic Ablative Body Radiotherapy for Intermediate Size (3–5 cm) Unresectable Colorectal Liver Metastases: a Systematic Review and Meta-analysis
por: Nieuwenhuizen, Sanne, et al.
Publicado: (2022) -
Locoregional Treatment of Metastatic Pancreatic Cancer Utilizing Resection, Ablation and Embolization: A Systematic Review
por: Timmer, Florentine E. F., et al.
Publicado: (2021) -
Thermal Ablation Compared to Partial Hepatectomy for Recurrent Colorectal Liver Metastases: An Amsterdam Colorectal Liver Met Registry (AmCORE) Based Study
por: Dijkstra, Madelon, et al.
Publicado: (2021) -
The Role of Neoadjuvant Chemotherapy in Repeat Local Treatment of Recurrent Colorectal Liver Metastases: A Systematic Review and Meta-Analysis
por: Dijkstra, Madelon, et al.
Publicado: (2021) -
Minimally Invasive Procedures in the Diagnosis and Treatment of Localized Prostate Cancer: an Interventional Radiologist’s Perspective
por: Avital, Yaniv, et al.
Publicado: (2022)